Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
| VISKAZIDE | 25MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256268 |
| VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
| VISKAZIDE | 50MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256271 |
| ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2025-11-26 | 202917 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Resolved | 2023-09-15 | 2023-09-20 | 204548 |
| ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-08-02 | 2023-08-03 | 200688 |
| ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-11-28 | 2024-01-23 | 211672 |
| ZESTORETIC | 12.5MG 20MG | TABLET | Actual shortage | 2024-12-05 | 2025-11-26 | 244985 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Discontinued | 2024-12-10 | 2024-12-10 | 245261 |
| VALSARTAN HCT | 25MG 320MG | TABLET | Discontinued | 2019-09-18 | 2020-01-09 | 94211 |